UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000014649
Receipt No. R000016961
Scientific Title A randomized, multicenter, phase II trial comparing neo-adjuvant therapy using pertuzumab and trastuzumab emtansine based on the dual HER2 blockade in patients with operable HER2-positive primary breast cancer(Neo-peaks study)
Date of disclosure of the study information 2014/08/01
Last modified on 2018/08/24 10:09:50

No. Disposal Last modified on Item of update
1 Insert 2014/07/25 18:21:01
2 Update 2014/07/25 18:26:24 UMIN ID1
UMIN ID2
3 Update 2014/07/26 18:54:27 Division name
4 Update 2014/07/26 18:57:05 IND to MHLW
5 Update 2014/07/26 19:02:14 IND to MHLW
6 Update 2014/07/26 19:03:02 IND to MHLW
7 Update 2014/07/28 18:59:25 IND to MHLW
8 Update 2014/07/31 15:48:50 Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
9 Update 2014/08/13 14:09:07 Narrative objectives1
Primary outcomes
Key secondary outcomes
10 Update 2014/08/13 17:20:27 Key inclusion criteria
Key exclusion criteria
11 Update 2014/08/13 17:21:19 Recruitment status
12 Update 2016/05/23 17:10:22 Recruitment status
13 Update 2016/05/23 17:12:30 Name of primary sponsor
Organization
Institutions
14 Update 2016/07/27 15:18:22 Last follow-up date
15 Update 2018/01/26 09:53:33 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
16 Update 2018/08/23 17:43:09 Public title
17 Update 2018/08/24 10:09:50 UMIN ID1
UMIN ID2


Contact us.